Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$405M |
| 2 |
Gilead Sciences
GILD
|
+$314M |
| 3 |
Union Pacific
UNP
|
+$229M |
| 4 |
Intel
INTC
|
+$224M |
| 5 |
Meta Platforms (Facebook)
META
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$342M |
| 2 |
SWY
SAFEWAY INC
SWY
|
+$210M |
| 3 |
TSMC
TSM
|
+$174M |
| 4 |
GSK
GSK
|
+$156M |
| 5 |
Johnson & Johnson
JNJ
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.05% |
| 2 | Technology | 11.94% |
| 3 | Consumer Discretionary | 11.2% |
| 4 | Industrials | 10.96% |
| 5 | Consumer Staples | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Telus
TU
$15.2B
| $104M | 0.22% |
6,268,600
+376,200
| +6% | +$6.51M |
|
77
Aptiv
APTV
$10.3B
| $103M | 0.22% |
1,297,400
+1,078,500
| +493% | +$81M |
|
|
SPLS
78
DELISTED
Staples Inc
SPLS
| $102M | 0.22% |
+6,277,679
| New | +$105M |
|
79
Clorox
CLX
$13.1B
| $101M | 0.21% |
913,500
-308,500
| -25% | -$33.5M |
|
|
MJN
80
DELISTED
Mead Johnson Nutrition Company
MJN
| $99M | 0.21% |
985,000
+432,800
| +78% | +$43.7M |
|
81
National Grid
NGG
$80.7B
| $98.7M | 0.21% |
1,583,512
+17,828
| +1% | +$1.17M |
|
82
O'Reilly Automotive
ORLY
$74.9B
| $98M | 0.21% |
6,796,410
+1,123,500
| +20% | +$15.1M |
|
83
Edwards Lifesciences
EW
$54B
| $95.2M | 0.2% |
4,010,400
+1,103,400
| +38% | +$24.8M |
|
84
Bausch Health
BHC
$2.33B
| $94.5M | 0.2% |
475,837
+436,848
| +1,120% | +$77.5M |
|
85
Baidu
BIDU
$35.9B
| $94.2M | 0.2% |
451,900
+170,400
| +61% | +$36.5M |
|
|
ECHO
86
EchoStar
ECHO
$25.6B
| $93.1M | 0.2% |
2,222,409
+10,859
| +0.5% | +$462K |
|
87
American Express
AXP
$230B
| $92.7M | 0.2% |
+1,186,600
| New | +$98.6M |
|
88
PPG Industries
PPG
$25.8B
| $92.2M | 0.2% |
+818,000
| New | +$93.7M |
|
89
Macerich
MAC
$6.96B
| $92.2M | 0.2% |
1,092,964
+421,464
| +63% | +$36.9M |
|
90
Usana Health Sciences
USNA
$254M
| $91.3M | 0.19% |
1,643,166
+47,400
| +3% | +$2.43M |
|
91
Pfizer
PFE
$152B
| $91.2M | 0.19% |
+2,764,053
| New | +$87.9M |
|
92
DuPont de Nemours
DD
$19.5B
| $90.4M | 0.19% |
+744,272
| New | +$88.3M |
|
|
NTT
93
DELISTED
Nippon Telegraph & Telephone
NTT
| $89M | 0.19% |
2,886,320
-512,380
| -15% | -$15.2M |
|
|
94
Johnson & Johnson
JNJ
$626B
| $87.2M | 0.19% |
867,200
-1,469,500
| -63% | -$149M |
|
95
Entergy
ETR
$49.7B
| $85.7M | 0.18% |
2,212,200
+277,400
| +14% | +$11.4M |
|
96
Ultrapar
UGP
$6.37B
| $85.5M | 0.18% |
8,467,400
-351,600
| -4% | -$3.43M |
|
97
Procter & Gamble
PG
$338B
| $85.5M | 0.18% |
1,043,128
-1,692,771
| -62% | -$146M |
|
|
SEE
98
DELISTED
Sealed Air
SEE
| $85.1M | 0.18% |
1,868,100
+1,719,500
| +1,157% | +$76.3M |
|
|
PCYC
99
DELISTED
PHARMACYCLICS INC
PCYC
| $84.9M | 0.18% |
331,700
+223,700
| +207% | +$43.2M |
|
100
Zoetis
ZTS
$31.1B
| $84.4M | 0.18% |
1,822,794
+1,172,294
| +180% | +$52.9M |
|
Similar funds
Jim Simons's Q1 2015 Portfolio in Review
As of Q1 2015, Jim Simons held 3,575 positions worth $47B, up 13% from $41.4B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
Jim Simons deployed $4.23B of net new capital in Q1 2015, opening 633 new positions and adding to 1,637 existing holdings. Its largest new stake was Amazon: 23,057,100 shares worth $429M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was McDonald's, an estimated $342M trimmed.
- Jim Simons's largest Q1 2015 buy was Amazon: 23,057,100 shares worth $429M.
- Jim Simons added most to Gilead Sciences in Q1 2015, an estimated $314M increase.
- Jim Simons's biggest Q1 2015 reduction was McDonald's, cutting an estimated $342M.
- Jim Simons fully exited SAFEWAY INC in Q1 2015, selling an estimated $210M.
- Jim Simons's ten largest holdings make up 9.9% of its $47B portfolio in Q1 2015.
- Jim Simons opened 633 new positions and closed 438 in Q1 2015.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $47B.
Based on Renaissance Technologies's 13F filing for Q1 2015, filed 13 May 2015.